Form 4: Skyward Specialty Insurance Group Executive Sells Shares Under 10b5-1 Plans

Skyward Specialty Insurance Group's EVP and Chief Actuary, Sandip A. Kapadia, sold a total of 6,035 shares of common stock between January 2, 2025 and January 6, 2025, under pre-arranged 10b5-1 trading plans.

Summary

• Sandip A. Kapadia, EVP and Chief Actuary at Skyward Specialty Insurance Group, sold 6,035 shares of common stock between January 2, 2025, and January 6, 2025.
• The sales were executed under two separate Rule 10b5-1 trading plans adopted on September 12, 2024, and August 8, 2024.
• The transactions included sales at weighted average prices ranging from $46.966 to $49.513 per share.
• The sales were made to cover taxes and fees incurred by the vesting of a restricted stock award on January 1, 2025.
• After these transactions, Mr. Kapadia beneficially owns 10,371 shares of Skyward Specialty Insurance Group common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by an executive under pre-arranged plans. It does not indicate any positive or negative sentiment about the company's performance.

Risks

• Executive stock sales can sometimes be perceived negatively by the market, although these sales were pre-planned under 10b5-1 trading plans.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often managed through pre-arranged trading plans to avoid accusations of insider trading. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a standard practice for executives at publicly traded companies to manage their stock sales.
• The reported sales are within the typical range of executive transactions and are not unusual in the context of the broader market.
• Comparable companies also have executives who use 10b5-1 plans to manage their stock sales.

Stakeholder Impact

• The stock sales may have a minor impact on the share price, but the pre-planned nature of the sales should mitigate any significant negative reaction.

Key Dates

Keywords

Skyward Specialty Insurance Group, SKWD, Sandip A. Kapadia, stock sale, Rule 10b5-1, insider trading, executive compensation, restricted stock, beneficial ownership